Journal of Hepatology
Volume 39, Issue 2 , Pages 239-244 , August 2003

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

  • Guido Colloredo

      Affiliations

    • Liver Unit, Seriate Hospital, Bergamo, Italy
    • Present address: Medical Division, Policlinico San Pietro, Bergamo, Italy.
  • ,
  • Maria Guido

      Affiliations

    • Pathology Department, Azienda Ospedale, Padova University, Padova, Italy
    • Corresponding Author InformationCorresponding author. Istituto di Anatomia Patologica, Via Gabelli, 61, 35100 Padova, Italy. Tel.: +39-049-8218991; fax: +39-049-8272277
  • ,
  • Aurelio Sonzogni

      Affiliations

    • Pathology Department, Ospedali Riuniti, Bergamo, Italy
  • ,
  • Gioacchino Leandro

      Affiliations

    • Istituto Gastroenterologico ‘S. De Bellis’, Castellana Grotte, Bari, Italy

Received 14 January 2003 ,Revised 4 April 2003 ,Accepted 7 April 2003.

References 

  1. Dienstang JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002;36:S152–S160
  2. Lok AS. Hepatitis B infection: pathogenesis and management. J Hepatol. 2000;32(Suppl 1):89–97
  3. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology. 2001;33:196–200
  4. Booth JC, O'Grady J, Neuberger J. Clinical guidelines of the management of hepatitis C. Gut. 2001;49(S1):1–21
  5. Leung N. Treatment of chronic hepatitis B: case selection and duration of therapy. J Gastroenterol Hepatol. 2002;17:409–414
  6. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–435
  7. The French METAVIR cooperative study group . Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15–20
  8. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al.  Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699
  9. Goldin RD, Goldin GJ, Burt AD, Dhillon AD, Hubscher S, Wyatt J, et al.  Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol. 1996;25:649–654
  10. Westin J, Lagging LM, Weistal R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver. 1999;19:183–187
  11. Abdi W, Milln JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med. 1979;139:667–669
  12. Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol. 1980;15:329–335
  13. Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol. 1983;18:27–32
  14. Maharaj B, Maharaj MG, Leary WP, Cooppan RM, Naran AD, Pirie D, et al.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;1:523–525
  15. Sherlock S. Needle biopsy of the liver. Diseases of the liver and biliary system. Oxford/London/Edinburgh/Boston/Melbourne: Blackwell scientific publication; 2001;
  16. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500
  17. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of randomised trials. Prog Cardiovasc Dis. 1985;27:335–371
  18. Altman DG. Inter-rater agreement. 1st ed.. Practical statistics for medical research. London: Chapman and Hall; 1991;
  19. Svensson E, Starmar KJE, Ekholm S, von Essen C, Johansson A. Analysis of interobserver disagreement in the assessment of subarachnoid blood and acute hydrocephalus on CT scan. Neurol Res. 1996;18:487–494
  20. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al.  The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23:1334–1340
  21. for the METAVIR, CLINIVIR, and DOSVIRC groups Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825–832
  22. Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol. 2003;38:223–229

PII: S0168-8278(03)00191-0

doi: 10.1016/S0168-8278(03)00191-0

Journal of Hepatology
Volume 39, Issue 2 , Pages 239-244 , August 2003